S&P Futures
5,872.50 +26.50 (+0.45%) Dow Futures
42,475.00 +154.00 (+0.36%) Nasdaq Futures
20,602.00 +103.25 (+0.50%) Russell 2000 Futures
2,232.90 +11.40 (+0.51%) Crude Oil
68.70 -3.08 (-4.29%) Gold
2,747.10 -7.50 (-0.27%)
After hours:
| Previous Close | 40.82 |
| Open | 40.99 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 40.58 - 41.48 |
| 52 Week Range | 40.24 - 69.16 |
| Volume | |
| Avg. Volume | 565,053 |
| Market Cap | 2.031B |
| Beta (5Y Monthly) | 1.47 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.86 |
| Earnings Date | Nov 11, 2024 - Nov 15, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Dec 02, 2021 |
| 1y Target Est | 58.00 |
PR NewswireAZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO
Azenta, Inc. (Nasdaq: AZTA) ("Azenta" or "the Company"), today announced that John P. Marotta will join the Company as President and CEO effective September 9, 2024, succeeding Dr. Stephen Schwartz, who is retiring following a distinguished tenure. Dr. Schwartz will remain as an advisor to Azenta to ensure a smooth and successful transition.
- PR Newswire
GENEWIZ from Azenta Life Sciences Celebrates 25 Years of Advancing Scientific Discoveries at GENEWIZ Week Event
Azenta, Inc. (Nasdaq: AZTA) today announced that GENEWIZ Multiomics and Synthesis Solutions from Azenta Life Sciences will be hosting its 25th anniversary and the launch of its annual GENEWIZ Week event on September 16 - 20. GENEWIZ Week will showcase our commitment to providing cutting-edge solutions to researchers worldwide through a series of workshops, an awards program, and engaging prizes and promotions.
